About

Still Threshold 12 is an independent resource on ibogaine risks and treatment-related deaths. Volta Loom helps people understand documented safety concerns, uncertainty, and treatment-related deaths in plain language so readers can weigh evidence and questions without marketing or clinical claims.

Safety first Plain language Evidence limits Human dignity

Our mission

We publish clear, careful explanations about the documented risks and uncertainties around the topic, operating as a standalone information resource rather than a treatment provider. If you are seeking clinical care, please consult licensed professionals; this site does not provide medical advice.

For readers who want practical orientation on services we describe, our services overview explains the types of resources and referrals we cover, and our front page context directs users to the most topical summaries.

Close-up view suggesting clinical notes and paper — visual context for treatment-safety discussion

Our editorial approach

We aggregate primary registries, published literature, and authoritative public resources to summarize known limits of evidence and open questions. Where appropriate we cite official sources: for example, methodological best practices often reference NIH-style registries and university-hosted systematic reviews — these inform how we weigh case reports and observational data (evidence-based medicine).

Primary sources firstWe prioritize registries, peer-reviewed studies, and official guidance over secondary summaries.
Transparent limitsWe flag uncertainty clearly, including gaps in case ascertainment and the limits of observational data.

What we cover

We publish summaries, plain-language explanations, and organized links to source material about treatment-related harms and evidence gaps. Content is organized into topical pages, case overviews, and thematic explainers; for readers comparing provider options, we also outline common questions to ask and what documented safety signals mean in practical terms. To see how cost and service descriptions fit into the overall landscape, some readers follow context on service availability at ibogaine treatment costs and service descriptions.

Audience

People considering the topic, their families, and clinicians seeking concise summaries of safety signals.

Organization

Pages grouped by topic: case overviews, risk-focused explainers, and procedural considerations — each page links to original reports and registries where available.

Landscape image suggesting clinical setting and documentation — reinforces editorial stance on evidence and safety

Editorial principles

  • Safety first: prioritize clarity about known harms and uncertainty.
  • Plain language: explain technical findings without jargon.
  • Evidence limits: make transparent what is unknown and why.
  • Transparency: cite sources and mark when information is preliminary.
  • Human dignity: center respectful language and avoid sensationalism.

Who this is for

This material is for non-expert readers seeking factual context and for families weighing safety signals. For clinical evaluation or immediate care needs consult a licensed provider or the nearest emergency service; our pages link to authoritative references such as university consensus statements and public health advisories when available (for background on methodological best practices, see a summary discussion at CDC).

Volta Loom helps people understand documented ibogaine safety concerns, uncertainty, and treatment-related deaths in plain language.

We also maintain an editorial link back to the site’s front page context in key explainers; for example, readers may navigate from topic pages back to curated summaries on the site overview and entry pathways as they orient themselves.

Independent by design

Still Threshold 12 is an independent information resource, not a clinic, medical provider, or licensed treatment center. Our content is editorial and not medical or legal advice. For questions about services or referrals, consult licensed professionals and review regulatory guidance such as institutional review pages and university guidance on evidence interpretation (peer review).

If you want to explore program descriptions or service listings we reference, the broader service landscape and cost context is available on specialist pages like the treatment-cost index at ibogaine treatment costs. For tailored support, please contact licensed care providers via channels listed on their official sites; we do not operate referral or intake services.